Pharmacologic management of atrial fibrillation

被引:10
作者
Riley, RD
Pritchett, ELC
机构
[1] DUKE UNIV, MED CTR, DEPT MED, DIV CLIN PHARMACOL, DURHAM, NC 27710 USA
[2] DUKE UNIV, MED CTR, DEPT MED, DIV CARDIOL, DURHAM, NC 27710 USA
[3] SINAI HOSP, DEPT MED, BALTIMORE, MD 21215 USA
关键词
antiarrhythmic drugs; thromboembolism; stroke; defibrillation;
D O I
10.1111/j.1540-8167.1997.tb00841.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pharmacologic Management of AF. In an era when many electrophysiologic problems are routinely with invasive procedures or implantable devices, drugs remain the cornerstones of treatment for atrial fibrillation. Atrial fibrillation may present as an episodic rhythm in patients who are primarily in sinus rhythm or it may be manifested as rhythm disorder that is permanent. Patients who appear to have an episodic rhythm disorder may be found to be in atrial fibrillation permanently when followed for long periods of time, and prognosis in the two forms is similar. It is, therefore, useful to consider them different manifestations in the same spectrum of disease. This review will address pharmacologic approaches designed to: (1) slow ventricular response; (2) restore sinus rhythm; (3) reduce occurrences of atrial fibrillation; and (4) prevent thromboembolic complications. Nonpharmacologic approaches to treating atrial fibrillation will be briefly reviewed.
引用
收藏
页码:818 / 829
页数:12
相关论文
共 96 条
  • [31] A PLACEBO-CONTROLLED TRIAL OF CONTINUOUS INTRAVENOUS DILTIAZEM INFUSION FOR 24-HOUR HEART-RATE CONTROL DURING ATRIAL-FIBRILLATION AND ATRIAL-FLUTTER - A MULTICENTER STUDY
    ELLENBOGEN, KA
    DIAS, VC
    PLUMB, VJ
    HEYWOOD, JT
    MIRVIS, DM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (04) : 891 - 897
  • [32] RESPONSE OF ATRIAL-FIBRILLATION TO THERAPY - ROLE OF ETIOLOGY AND LEFT ATRIAL DIAMETER
    EWY, GA
    ULFERS, L
    HAGER, WD
    ROSENFELD, AR
    ROESKE, WR
    GOLDMAN, S
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 1980, 13 (02) : 119 - 123
  • [33] WARFARIN IN THE PREVENTION OF STROKE ASSOCIATED WITH NONRHEUMATIC ATRIAL-FIBRILLATION
    EZEKOWITZ, MD
    BRIDGERS, SL
    JAMES, KE
    CARLINER, NH
    COLLING, CL
    GORNICK, CC
    KRAUSESTEINRAUF, H
    KURTZKE, JF
    NAZARIAN, SM
    RADFORD, MJ
    RICKLES, FR
    SHABETAI, R
    DEYKIN, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (20) : 1406 - 1412
  • [34] DIGOXIN FOR ATRIAL-FIBRILLATION - A DRUG WHOSE TIME HAS GONE
    FALK, RH
    LEAVITT, JI
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 114 (07) : 573 - 575
  • [35] GAJEWSKI J, 1981, JAMA-J AM MED ASSOC, V245, P1540
  • [36] CATHETER TECHNIQUE FOR CLOSED-CHEST ABLATION OF THE ATRIOVENTRICULAR-CONDUCTION SYSTEM - A THERAPEUTIC ALTERNATIVE FOR THE TREATMENT OF REFRACTORY SUPRA-VENTRICULAR TACHYCARDIA
    GALLAGHER, JJ
    SVENSON, RH
    KASELL, JH
    GERMAN, LD
    BARDY, GH
    BROUGHTON, A
    CRITELLI, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (04) : 194 - 200
  • [37] FAILURE OF LONG-TERM DIGITALIZATION TO PREVENT RAPID VENTRICULAR RESPONSE IN PATIENTS WITH PAROXYSMAL ATRIAL-FIBRILLATION
    GALUN, E
    FLUGELMAN, MY
    GLICKSON, M
    ELIAKIM, M
    [J]. CHEST, 1991, 99 (04) : 1038 - 1040
  • [38] Gold H, 1939, J PHARMACOL EXP THER, V67, P224
  • [39] INEFFICACY OF THERAPEUTIC SERUM LEVELS OF DIGOXIN IN CONTROLLING VENTRICULAR RATE IN ATRIAL-FIBRILLATION
    GOLDMAN, S
    PROBST, P
    SELZER, A
    COHN, K
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1975, 35 (05) : 651 - 655
  • [40] EFFECT OF DIGOXIN ON ATRIOVENTRICULAR-CONDUCTION - STUDIES IN PATIENTS WITH AND WITHOUT CARDIAC AUTONOMIC INNERVATION
    GOODMAN, DJ
    ROSSEN, RM
    CANNOM, DS
    RIDER, AK
    HARRISON, DC
    [J]. CIRCULATION, 1975, 51 (02) : 251 - 256